SlideShare a Scribd company logo
Dose-Response
Relationships for
Model Normal Tissues
Presented by- Dr. Rashmi Yadav
Moderated by- Dr. Ayush Garg
Introduction
• Dose-response relationships are important for prescribing a proper therapy
course
• Response is quantified as either increase of radiation effects in severity, or
frequency (% incidence), or both
• In vitro vs. in vivo experiments
• Different cells have different response based on their reproduction rate
(acute vs. late effects)
• With increasing radiation dose, radiation effects may increase in severity
(i.e., grade), in frequency (i.e., incidence), or both.
Cell Survival Curve Parameters
• D1 – initial slope (the dose required to
reduce the fraction of surviving cells to
37% of its previous value); D0 – final
slope
• Dq – quasi-threshold, the dose at which
the straight portion of the survival curve,
extrapolated backward, cuts the dose axis
drawn through a survival fraction of unity
• n – extrapolation number
• Radiosensitive cells are characterized by
curves with steep slope D0 and/or small
shoulder (low n)
Survival curves and LQ model
• Linear-quadratic model assumes there are two components to cell killing,
only two parameters
• An adequate representation of the data up to doses used as daily fractions in
clinical radiotherapy
α/𝜷 ratios
• If the dose-response relationship is adequately represented by LQ-model:
• The dose at which αD=𝜷D2 , or D= α/𝜷
• The α/𝜷 ratios can be inferred from multi-fraction experiments, assuming : –
each dose in fractionated regime produces the same effect
there is full repair of sub-lethal damage between fractions
there is no cell proliferation between fractions
• For the total dose D divided in n equal fractions of dose d
• If the reciprocal dose 1/dn is plotted against the dose per fraction d, the ratio
of the intercept/slope gives α/𝜷
Dose- response relationships
• With increasing radiation dose, radiation
effects may increase in severity (i.e.,
grade), in frequency (i.e., incidence), or
both.
• Curves are typically sigmoid (S)-shaped for
both tumor and normal cells (y axis is
“flipped” compared to cell survival curves)
• Therapeutic ratio (index) TR: tumor
response for a fixed level of a normal
tissue damage
Therapeutic ratio
• The ratio of the tumor response for a
fixed level of normal tissue damage has
been called either the therapeutic
ratio or the therapeutic index.
• The time factor is often employed to
manipulate the TR (hyper-fractionation
for sparing of late responding normal
tissues)
• Addition of a drug, a chemotherapy
agent, or a radiosensitizer may improve
the TR
Mechanisms of cell death after irradiation
• Cells die by various mechanism when they are exposed to radiation
1. Mitotic- linked cell death
2. Necrotic cell death
3. Apoptotic cell death
4. Autophagic cell death
5. Bystander induced cell death
6. Senescence
• The main target of radiation is cell’s DNA; single breaks are often reparable,
double breaks lethal
• Mitotic death – cells die attempting to divide, primarily due to asymmetric
chromosome aberrations; most common mechanism
• Apoptosis – programmed cell death; characterized by a predefined sequence
of events resulting in cell separation in apoptotic bodies-Cell shrinks,
chromatin condenses, cell breaks into fragments, no inflammation.
• Bystander (abscopal) effect – cells directly affected by radiation release
cytotoxic molecules inducing death in neighbouring cells
• Additional mechanisms under investigation: –
1. Autophagic: cell degradation of unnecessary or dysfunctional cellular
components through lysosomes
2. Necrotic: cell swells, leakage of membrane, inflammation
3. Entosis: cell death by invasion
Assays for dose-response relationships
• Clonogenic end points
• Depend directly on reproductive integrity of individual cells (cell survival)
• Cell regrowth in situ and by transplantation into another site
• Functional end points
• Reflect the minimum number of functional cells remaining in a tissue or
organ
• Dose-response can be inferred from multi-fraction experiments
• More pertinent to radiation therapy
Early and late responding tissues
• Observation: cells of different tissues demonstrate different response
rates to the same radiation dose
• Rapidly dividing self-renewing tissues respond early to the effects of
radiation; examples: skin, intestinal epithelium, bone-marrow
• Late-responding tissues: spinal cord, lung, kidney
• Early or late radiation response reflects different cell turnover rates
CLONOGENIC END POINTS
Skin
Colonies
Skin colonies
• Central area is given a test dose
and monitored for cell re-
growth
• Image showing nodule of mouse
skin regrowing from single
survival cell in treated area
• There are practical limits to the range
of doses
• Determine D0 =1.35 Gy from the single
dose curve
• Dq =3.4 Gy from the curve separation
• Values for D0 and Dq are similar to
those obtained in vitro
Crypt cells of the mouse
jejunum
• Intestinal epithelium is a classic example of a self renewing
system
• Crypt cells divide rapidly and replenish cells on the top of
villi
• Mice are given total body irradiation and are sacrificed
after 3.5 days
• Radiation effect is assessed based on the number of
regenerating crypts per circumference of the sectioned
jejunum
• A: Section of mouse jejunum taken 3.5 days after a total body dose in excess of
10 Gy. Note the shortened villi and the regenerating crypts.
• B: Regenerating crypts shown at a higher magnification.
-Survival curves for crypt cells in the mouse jejunum
exposed to single or multiple doses of gamma-rays (1–20
fractions). The score of radiation damage is the number
of surviving cells per circumference (i.e., the number of
regenerating crypts per circumference of the sectioned
jejunum). This quantity is plotted on a logarithmic scale
against radiation dose on a linear scale
-The D0 for the single-dose survival curve is about 1.3 Gy.
-The shoulder of the survival curve is very large. The
separation between the single-dose survival and two-
dose survival curves indicates that the Dq is 4 to 4.5 Gy.
Testes Stem Cells
A: Histology of normal testis.
B: Histology of testis 35 days after a dose of 9 Gy of
gamma-radiation. Some tubules are completely devoid
of spermatogenic epithelium and some are not.
Single- and split- dose survival
curves for spermatogenic stem
cells of the mouse testis. The D0
is about 1.68 Gy. The Dq, assessed
from the horizontal separation of
the single- and split-dose curves,
is about 2.7 Gy.
Kidney tubules
• Late responding tissue
• One kidney per mouse is irradiated and examined 60 weeks later
• Rate of response as time required for depletion of the epithelium after a single
dose of 14Gy: – 3 days in jejunum – 12 to 24 days in the skin – 30 days in the
seminiferous tubules of the testes – 300 days in the kidney tubules
A. Normal ,proximal tubules in contact with the capsule
B: Sixty weeks after irradiation with 13 Gy. Note normal proximal tubules and glomeruli amid
ghosts of de-epithelialized tubules
The time required for depletion of the epithelium after a single dose of
14 Gy is about
• 3 days in the jejunum
• 12 to 24 days in the skin
• 30 days in the seminiferous tubules of the testes
• 300 days in the kidney tubules.
Clonogenic End Points: Donor
Recipient Approach
• Systems in which cell survival is assessed by transplantation into
another site:
 Bone-marrow stem cells
Thyroid
Mammary gland cells
Cells Transplanted to Another Site
Bone Marrow Stem Cells
From the donor mouse, a cell suspension is
made of nucleated isologous bone marrow.
A known number of cells are injected into
recipient mice previously irradiated with a 9-
Gy total body dose. The spleen is removed
from each recipient mouse 9 or 10 days later,
and the number of nodules are counted.
• About 104 cells must be injected into a recipient animal to produce one spleen
colony because most of the cells in the nucleated isologous bone marrow are
fully differentiated cells and would never be capable of forming a colony.
Mammary and Thyroid Cells
• To generate a survival curve for mammary or thyroid gland cells in the rat, cells
may be irradiated in vivo before the gland is removed from donor animals and
treated with enzymes to obtain a monodispersed cell suspension. Known
numbers of cells are injected into the inguinal or interscapular white fat pads of
recipient animals.
• Under appropriate host conditions and grafted cell numbers, the injection of
mammary cells gives rise to mammary structures that are morphologically and
functionally normal. One such mammary structure may develop from a single
cell. By 3.5 weeks after the injection of mammary cells, positive growth is
indicated by alveolar units.
Clonogenic Assays:
Summary
• Radiosensitivity of a cell line is
determined by the curve shoulder
(Dq parameter)
• Significant variability observed
Functional End Points
Dose-response Curves For Functional
End Points
• Can be obtained on pig and rodent skin by assessing skin reaction
• For mouse lung system based on breathing rate, assess early and
late response
• Spinal cords of rats by observing myelopathy after local irradiation
complex system – various syndromes are similar to those described
in humans
Skin
Lung
• Early response (i.e., Pneumonitis) by 16-36 weeks,
• Late response (i.e., Fibrosis) by 52 weeks
Spinal Cord System
• Assess late damage caused by local irradiation of the spinal cords of rats
• First symptoms develop after 4 to 12 months
• Delayed injuries peak at 1 to 2 years post-irradiation
• The regimen of dose delivery has a strong effect on the resultant effect such
as the extend of necrosis, loss of functionality, etc.
• Obtain the information on the tolerance to radiation
• Dose-response relationship is steep
• Fractionation demonstrates dramatic sparing
• Latency decreases with increase in dose
• The region of cord irradiated
• The total volume of irradiated tissue has to have an effect on the
resultant injury
• Functional subunits (FSUs) in a spinal cord are arranged in linear
fashion therefore above a certain length of ~1cm the dependence is
very weak
INFERRING THE RATIO α/𝜷 FROM MULTIFRACTION
EXPERIMENTS IN NONCLONOGENIC SYSTEMS
• The dose–response relationship is represented adequately by the LQ formulation:
•S= e -αD-𝜷D2
• in which S is the fraction of cells surviving a dose, D, and α and 𝜷 are constants.
• Each dose in a fractionated regimen produces the same biologic effect.
• Full repair of sublethal damage takes place between dose fractions, but no cell
proliferation occurs.
SUMMARY
• The relationship between dose and incidence is sigmoid for both tumor control and normal tissue
damage.
• The ratio of tumor response to normal tis- sue damage is called the therapeutic ratio or therapeutic
index.
• The therapeutic index can be manipulated by dose fractionation or by the use of drugs that
preferentially increase tumor response.
• After irradiation, most cells die a mitotic death; that is, they die in attempting the next or a later
mitosis. In some tissues, cells die by apoptosis, which is a programmed cell death.
• Systems involving clonogenic end points (i.e., cell survival) for cells of normal tissues include some
in which cells regrow in situ and some in which cells are transplanted to another site.
• In situ regrowth techniques include skin colonies, crypts in the jejunum, testes stem cells,
and kidney tubules. Single dose experiments can yield the slope (D0) of the dose-
response curve over a range of high doses. Multifraction experiments allow the whole
dose-response curve to be reconstructed.
• Systems in which cell survival is assessed by transplantation into another site include bone
marrow stem cells, thyroid cells, and mammary cells.
• Dose–response curves for mammary and thyroid cells can be obtained by transplanting
them into fat pads of recipient animals.
• The radiosensitivity of cells from normal tissues varies widely. The width of the shoulder of
the curve is the principal variable. Jejunal crypt cells have a very large shoulder; bone
marrow stem cells have little, if any, shoulder. Most other cell types studied in clonogenic
assays fall in between.
Dose–response curves for functional end points, distinct from cell survival, can be
obtained as follows:
1. Pig skin and rodent skin—by measuring skin reactions.
2. Early and late response of the lung—by measuring breathing rate.
3. Spinal cord—by observing myelopathy
a. Paralysis develops after a latency of months to years.
b. Early lesions are limited to white matter; late delayed injury may have a vascular basis.
c. Spinal cord damage is very sensitive to fractionation—α/𝜷 of about 1.5 Gy.
d. Sublethal damage repair probably has “fast” and “slow” components.
e. If multiple fractions per day are used, the interfraction interval should be at least 6 to 8 hours.
f. Functional subunits are arranged serially like links in a chain.
g. For short lengths of cord, tolerance dose varies markedly with cord length irradiated.
• The shape of the dose–response relationship for functional end points, obtained from
multi-fraction experiments, is more pertinent to radiotherapy than clonogenic assays.
• The ratio α/𝜷 (the dose at which the linear and quadratic components of radiation
damage are equal) may be inferred from multifraction experiments in systems scoring
non-clonogenic end points.
Dose-Response Relationships for Model Normal Tissues

More Related Content

What's hot

ICRU 89 summary & beyond converted
ICRU 89 summary & beyond convertedICRU 89 summary & beyond converted
ICRU 89 summary & beyond converted
Dr. Abhishek Basu
 
Radiotherapy lymphoma
Radiotherapy lymphoma Radiotherapy lymphoma
Radiotherapy lymphoma
vrinda singla
 
HYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPYHYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPY
Rejil Rajan
 
Altered fractionation kiran
Altered fractionation   kiranAltered fractionation   kiran
Altered fractionation kiran
Kiran Ramakrishna
 
Radiosensitivity and cell age in the mitotic cycle
Radiosensitivity and cell age in the mitotic cycleRadiosensitivity and cell age in the mitotic cycle
Radiosensitivity and cell age in the mitotic cycle
Sneha George
 
Stereotactic body radiotherapy
Stereotactic body radiotherapyStereotactic body radiotherapy
Stereotactic body radiotherapy
Nanditha Nukala
 
Concept of bed in radiobiology
Concept of bed in radiobiologyConcept of bed in radiobiology
Concept of bed in radiobiology
RANJITH C P
 
Radioimmunotherapy
RadioimmunotherapyRadioimmunotherapy
Radioimmunotherapy
Ali Azher
 
Time, dose & fractionation,
Time, dose & fractionation,Time, dose & fractionation,
Time, dose & fractionation,
Swarnita Sahu
 
Sib.si
Sib.siSib.si
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
DrAyush Garg
 
Evolution of Fractionation and Conventional Fractionation in Radiotherapy
Evolution of Fractionation and Conventional Fractionation in RadiotherapyEvolution of Fractionation and Conventional Fractionation in Radiotherapy
Evolution of Fractionation and Conventional Fractionation in RadiotherapyNikhil Sebastian
 
Chemical modifiers of radiotherapy
Chemical modifiers of radiotherapyChemical modifiers of radiotherapy
Chemical modifiers of radiotherapy
Dr.Saadvik Raghuram
 
Icru – 83 dr. upasna
Icru – 83  dr. upasnaIcru – 83  dr. upasna
Icru – 83 dr. upasna
Upasna Saxena
 
Volumetric Modulated Arc Therapy
Volumetric Modulated Arc TherapyVolumetric Modulated Arc Therapy
Volumetric Modulated Arc Therapyfondas vakalis
 
Radiation response modifiers
Radiation response modifiersRadiation response modifiers
Radiation response modifiers
Himanshu Mekap
 
Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]
Upasna Saxena
 
Radioimmunotherapy
RadioimmunotherapyRadioimmunotherapy
Radioimmunotherapy
Ravi Krishna
 
Cell Survival Curves by Dr.Abhilash.pptx
Cell Survival Curves by Dr.Abhilash.pptxCell Survival Curves by Dr.Abhilash.pptx
Cell Survival Curves by Dr.Abhilash.pptx
AbhilashBanerjee3
 
Motion Management in Radiation Therapy
Motion Management in Radiation TherapyMotion Management in Radiation Therapy
Motion Management in Radiation Therapy
Teekendra Singh Faujdar
 

What's hot (20)

ICRU 89 summary & beyond converted
ICRU 89 summary & beyond convertedICRU 89 summary & beyond converted
ICRU 89 summary & beyond converted
 
Radiotherapy lymphoma
Radiotherapy lymphoma Radiotherapy lymphoma
Radiotherapy lymphoma
 
HYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPYHYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPY
 
Altered fractionation kiran
Altered fractionation   kiranAltered fractionation   kiran
Altered fractionation kiran
 
Radiosensitivity and cell age in the mitotic cycle
Radiosensitivity and cell age in the mitotic cycleRadiosensitivity and cell age in the mitotic cycle
Radiosensitivity and cell age in the mitotic cycle
 
Stereotactic body radiotherapy
Stereotactic body radiotherapyStereotactic body radiotherapy
Stereotactic body radiotherapy
 
Concept of bed in radiobiology
Concept of bed in radiobiologyConcept of bed in radiobiology
Concept of bed in radiobiology
 
Radioimmunotherapy
RadioimmunotherapyRadioimmunotherapy
Radioimmunotherapy
 
Time, dose & fractionation,
Time, dose & fractionation,Time, dose & fractionation,
Time, dose & fractionation,
 
Sib.si
Sib.siSib.si
Sib.si
 
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
 
Evolution of Fractionation and Conventional Fractionation in Radiotherapy
Evolution of Fractionation and Conventional Fractionation in RadiotherapyEvolution of Fractionation and Conventional Fractionation in Radiotherapy
Evolution of Fractionation and Conventional Fractionation in Radiotherapy
 
Chemical modifiers of radiotherapy
Chemical modifiers of radiotherapyChemical modifiers of radiotherapy
Chemical modifiers of radiotherapy
 
Icru – 83 dr. upasna
Icru – 83  dr. upasnaIcru – 83  dr. upasna
Icru – 83 dr. upasna
 
Volumetric Modulated Arc Therapy
Volumetric Modulated Arc TherapyVolumetric Modulated Arc Therapy
Volumetric Modulated Arc Therapy
 
Radiation response modifiers
Radiation response modifiersRadiation response modifiers
Radiation response modifiers
 
Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]
 
Radioimmunotherapy
RadioimmunotherapyRadioimmunotherapy
Radioimmunotherapy
 
Cell Survival Curves by Dr.Abhilash.pptx
Cell Survival Curves by Dr.Abhilash.pptxCell Survival Curves by Dr.Abhilash.pptx
Cell Survival Curves by Dr.Abhilash.pptx
 
Motion Management in Radiation Therapy
Motion Management in Radiation TherapyMotion Management in Radiation Therapy
Motion Management in Radiation Therapy
 

Similar to Dose-Response Relationships for Model Normal Tissues

Dose response dr.rekha arya
Dose response dr.rekha aryaDose response dr.rekha arya
Dose response dr.rekha arya
Dr Rekha Arya
 
Dose response
Dose responseDose response
Dose response
Dr Rekha Arya
 
Cell survival curve ppt.
Cell survival curve ppt.Cell survival curve ppt.
Cell survival curve ppt.
Luri Borah
 
Cell survival curves
Cell survival curvesCell survival curves
Cell survival curves
SavioJames4
 
6th radiobiology- cell survival curves
6th  radiobiology- cell survival curves6th  radiobiology- cell survival curves
6th radiobiology- cell survival curves
Gowtham Manimaran
 
TIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATIONTIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATION
Isha Jaiswal
 
Oltre l’alfa/beta: ipotesi di coinvolgimento dell’endotelio e modelli preditt...
Oltre l’alfa/beta: ipotesi di coinvolgimento dell’endotelio e modelli preditt...Oltre l’alfa/beta: ipotesi di coinvolgimento dell’endotelio e modelli preditt...
Oltre l’alfa/beta: ipotesi di coinvolgimento dell’endotelio e modelli preditt...
Gemelli Advanced Radiation Therapy
 
4 r's of radiobiology and dose rate effects
4 r's of radiobiology and dose rate effects4 r's of radiobiology and dose rate effects
4 r's of radiobiology and dose rate effects
Dr.laxman Pandey
 
5 Rs OF RADIOBIOLOGY.pptx
5 Rs OF RADIOBIOLOGY.pptx5 Rs OF RADIOBIOLOGY.pptx
5 Rs OF RADIOBIOLOGY.pptx
Suvetha Chavarkkad
 
CELL SURVIVAL CURVE.pptx
CELL SURVIVAL CURVE.pptxCELL SURVIVAL CURVE.pptx
CELL SURVIVAL CURVE.pptx
masthan basha
 
Chap 5 fractionated radiation and the dose rate effect
Chap 5 fractionated radiation and the dose rate effectChap 5 fractionated radiation and the dose rate effect
Chap 5 fractionated radiation and the dose rate effectKorea Cancer Center Hospital
 
Fractionation in Radiotherapy
Fractionation in RadiotherapyFractionation in Radiotherapy
Fractionation in Radiotherapyameneh haghbin
 
4 R's of radiobiology
 4 R's of radiobiology 4 R's of radiobiology
4 R's of radiobiology
Swarnita Sahu
 
To use or not to use the LQ model at “high” radiation doses
To use or not to use the LQ model at “high” radiation doses To use or not to use the LQ model at “high” radiation doses
To use or not to use the LQ model at “high” radiation doses
Santam Chakraborty
 
Anticancer drug screening
Anticancer drug screeningAnticancer drug screening
Anticancer drug screeningshishirkawde
 
Tissue radiosensitivity
Tissue radiosensitivityTissue radiosensitivity
Tissue radiosensitivityDeepaGautam
 
Gowtham's 3rd radiobiology
Gowtham's  3rd radiobiology Gowtham's  3rd radiobiology
Gowtham's 3rd radiobiology
Gowtham Manimaran
 
PMED Opening Workshop - Regrowth Rates of Tumors after Radiation Vary Dependi...
PMED Opening Workshop - Regrowth Rates of Tumors after Radiation Vary Dependi...PMED Opening Workshop - Regrowth Rates of Tumors after Radiation Vary Dependi...
PMED Opening Workshop - Regrowth Rates of Tumors after Radiation Vary Dependi...
The Statistical and Applied Mathematical Sciences Institute
 
●TRANSPLANTATION IMMUNOLOGY SEMINAR BY RANTA OWAIS.pptx
●TRANSPLANTATION IMMUNOLOGY SEMINAR BY RANTA OWAIS.pptx●TRANSPLANTATION IMMUNOLOGY SEMINAR BY RANTA OWAIS.pptx
●TRANSPLANTATION IMMUNOLOGY SEMINAR BY RANTA OWAIS.pptx
RantaUvesh
 

Similar to Dose-Response Relationships for Model Normal Tissues (20)

Dose response dr.rekha arya
Dose response dr.rekha aryaDose response dr.rekha arya
Dose response dr.rekha arya
 
Dose response
Dose responseDose response
Dose response
 
Cell survival curve ppt.
Cell survival curve ppt.Cell survival curve ppt.
Cell survival curve ppt.
 
Chapter3 cell survival curve
Chapter3 cell survival curveChapter3 cell survival curve
Chapter3 cell survival curve
 
Cell survival curves
Cell survival curvesCell survival curves
Cell survival curves
 
6th radiobiology- cell survival curves
6th  radiobiology- cell survival curves6th  radiobiology- cell survival curves
6th radiobiology- cell survival curves
 
TIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATIONTIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATION
 
Oltre l’alfa/beta: ipotesi di coinvolgimento dell’endotelio e modelli preditt...
Oltre l’alfa/beta: ipotesi di coinvolgimento dell’endotelio e modelli preditt...Oltre l’alfa/beta: ipotesi di coinvolgimento dell’endotelio e modelli preditt...
Oltre l’alfa/beta: ipotesi di coinvolgimento dell’endotelio e modelli preditt...
 
4 r's of radiobiology and dose rate effects
4 r's of radiobiology and dose rate effects4 r's of radiobiology and dose rate effects
4 r's of radiobiology and dose rate effects
 
5 Rs OF RADIOBIOLOGY.pptx
5 Rs OF RADIOBIOLOGY.pptx5 Rs OF RADIOBIOLOGY.pptx
5 Rs OF RADIOBIOLOGY.pptx
 
CELL SURVIVAL CURVE.pptx
CELL SURVIVAL CURVE.pptxCELL SURVIVAL CURVE.pptx
CELL SURVIVAL CURVE.pptx
 
Chap 5 fractionated radiation and the dose rate effect
Chap 5 fractionated radiation and the dose rate effectChap 5 fractionated radiation and the dose rate effect
Chap 5 fractionated radiation and the dose rate effect
 
Fractionation in Radiotherapy
Fractionation in RadiotherapyFractionation in Radiotherapy
Fractionation in Radiotherapy
 
4 R's of radiobiology
 4 R's of radiobiology 4 R's of radiobiology
4 R's of radiobiology
 
To use or not to use the LQ model at “high” radiation doses
To use or not to use the LQ model at “high” radiation doses To use or not to use the LQ model at “high” radiation doses
To use or not to use the LQ model at “high” radiation doses
 
Anticancer drug screening
Anticancer drug screeningAnticancer drug screening
Anticancer drug screening
 
Tissue radiosensitivity
Tissue radiosensitivityTissue radiosensitivity
Tissue radiosensitivity
 
Gowtham's 3rd radiobiology
Gowtham's  3rd radiobiology Gowtham's  3rd radiobiology
Gowtham's 3rd radiobiology
 
PMED Opening Workshop - Regrowth Rates of Tumors after Radiation Vary Dependi...
PMED Opening Workshop - Regrowth Rates of Tumors after Radiation Vary Dependi...PMED Opening Workshop - Regrowth Rates of Tumors after Radiation Vary Dependi...
PMED Opening Workshop - Regrowth Rates of Tumors after Radiation Vary Dependi...
 
●TRANSPLANTATION IMMUNOLOGY SEMINAR BY RANTA OWAIS.pptx
●TRANSPLANTATION IMMUNOLOGY SEMINAR BY RANTA OWAIS.pptx●TRANSPLANTATION IMMUNOLOGY SEMINAR BY RANTA OWAIS.pptx
●TRANSPLANTATION IMMUNOLOGY SEMINAR BY RANTA OWAIS.pptx
 

More from Dr.Rashmi Yadav

Carcinoma nasopharynx
Carcinoma nasopharynxCarcinoma nasopharynx
Carcinoma nasopharynx
Dr.Rashmi Yadav
 
primary cutenous lymphoma..
primary cutenous lymphoma..primary cutenous lymphoma..
primary cutenous lymphoma..
Dr.Rashmi Yadav
 
Radiotherapy planning in carcinoma urinary bladder
Radiotherapy planning in carcinoma urinary bladder Radiotherapy planning in carcinoma urinary bladder
Radiotherapy planning in carcinoma urinary bladder
Dr.Rashmi Yadav
 
RT in Ca esophagus
RT in Ca esophagusRT in Ca esophagus
RT in Ca esophagus
Dr.Rashmi Yadav
 
Re Radiation
Re RadiationRe Radiation
Re Radiation
Dr.Rashmi Yadav
 
trials on Chemotherapy in breast cancer
trials on Chemotherapy in breast cancer trials on Chemotherapy in breast cancer
trials on Chemotherapy in breast cancer
Dr.Rashmi Yadav
 
Locally advanced ca breast LABC
Locally advanced ca breast LABCLocally advanced ca breast LABC
Locally advanced ca breast LABC
Dr.Rashmi Yadav
 
Role of chemotherapy and radiotherapy in Ca gall bladder
Role of  chemotherapy and radiotherapy in Ca gall bladderRole of  chemotherapy and radiotherapy in Ca gall bladder
Role of chemotherapy and radiotherapy in Ca gall bladder
Dr.Rashmi Yadav
 
Primary CNS Lymphoma
Primary CNS Lymphoma Primary CNS Lymphoma
Primary CNS Lymphoma
Dr.Rashmi Yadav
 
Role of radiotherapy and chemotherapy in oral cavity cancer
Role of radiotherapy and chemotherapy in oral cavity cancerRole of radiotherapy and chemotherapy in oral cavity cancer
Role of radiotherapy and chemotherapy in oral cavity cancer
Dr.Rashmi Yadav
 

More from Dr.Rashmi Yadav (10)

Carcinoma nasopharynx
Carcinoma nasopharynxCarcinoma nasopharynx
Carcinoma nasopharynx
 
primary cutenous lymphoma..
primary cutenous lymphoma..primary cutenous lymphoma..
primary cutenous lymphoma..
 
Radiotherapy planning in carcinoma urinary bladder
Radiotherapy planning in carcinoma urinary bladder Radiotherapy planning in carcinoma urinary bladder
Radiotherapy planning in carcinoma urinary bladder
 
RT in Ca esophagus
RT in Ca esophagusRT in Ca esophagus
RT in Ca esophagus
 
Re Radiation
Re RadiationRe Radiation
Re Radiation
 
trials on Chemotherapy in breast cancer
trials on Chemotherapy in breast cancer trials on Chemotherapy in breast cancer
trials on Chemotherapy in breast cancer
 
Locally advanced ca breast LABC
Locally advanced ca breast LABCLocally advanced ca breast LABC
Locally advanced ca breast LABC
 
Role of chemotherapy and radiotherapy in Ca gall bladder
Role of  chemotherapy and radiotherapy in Ca gall bladderRole of  chemotherapy and radiotherapy in Ca gall bladder
Role of chemotherapy and radiotherapy in Ca gall bladder
 
Primary CNS Lymphoma
Primary CNS Lymphoma Primary CNS Lymphoma
Primary CNS Lymphoma
 
Role of radiotherapy and chemotherapy in oral cavity cancer
Role of radiotherapy and chemotherapy in oral cavity cancerRole of radiotherapy and chemotherapy in oral cavity cancer
Role of radiotherapy and chemotherapy in oral cavity cancer
 

Recently uploaded

Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 

Recently uploaded (20)

Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 

Dose-Response Relationships for Model Normal Tissues

  • 1. Dose-Response Relationships for Model Normal Tissues Presented by- Dr. Rashmi Yadav Moderated by- Dr. Ayush Garg
  • 2. Introduction • Dose-response relationships are important for prescribing a proper therapy course • Response is quantified as either increase of radiation effects in severity, or frequency (% incidence), or both • In vitro vs. in vivo experiments • Different cells have different response based on their reproduction rate (acute vs. late effects) • With increasing radiation dose, radiation effects may increase in severity (i.e., grade), in frequency (i.e., incidence), or both.
  • 3. Cell Survival Curve Parameters • D1 – initial slope (the dose required to reduce the fraction of surviving cells to 37% of its previous value); D0 – final slope • Dq – quasi-threshold, the dose at which the straight portion of the survival curve, extrapolated backward, cuts the dose axis drawn through a survival fraction of unity • n – extrapolation number • Radiosensitive cells are characterized by curves with steep slope D0 and/or small shoulder (low n)
  • 4. Survival curves and LQ model • Linear-quadratic model assumes there are two components to cell killing, only two parameters • An adequate representation of the data up to doses used as daily fractions in clinical radiotherapy
  • 5. α/𝜷 ratios • If the dose-response relationship is adequately represented by LQ-model: • The dose at which αD=𝜷D2 , or D= α/𝜷 • The α/𝜷 ratios can be inferred from multi-fraction experiments, assuming : – each dose in fractionated regime produces the same effect there is full repair of sub-lethal damage between fractions there is no cell proliferation between fractions
  • 6. • For the total dose D divided in n equal fractions of dose d • If the reciprocal dose 1/dn is plotted against the dose per fraction d, the ratio of the intercept/slope gives α/𝜷
  • 7. Dose- response relationships • With increasing radiation dose, radiation effects may increase in severity (i.e., grade), in frequency (i.e., incidence), or both. • Curves are typically sigmoid (S)-shaped for both tumor and normal cells (y axis is “flipped” compared to cell survival curves) • Therapeutic ratio (index) TR: tumor response for a fixed level of a normal tissue damage
  • 8. Therapeutic ratio • The ratio of the tumor response for a fixed level of normal tissue damage has been called either the therapeutic ratio or the therapeutic index. • The time factor is often employed to manipulate the TR (hyper-fractionation for sparing of late responding normal tissues) • Addition of a drug, a chemotherapy agent, or a radiosensitizer may improve the TR
  • 9. Mechanisms of cell death after irradiation • Cells die by various mechanism when they are exposed to radiation 1. Mitotic- linked cell death 2. Necrotic cell death 3. Apoptotic cell death 4. Autophagic cell death 5. Bystander induced cell death 6. Senescence
  • 10. • The main target of radiation is cell’s DNA; single breaks are often reparable, double breaks lethal • Mitotic death – cells die attempting to divide, primarily due to asymmetric chromosome aberrations; most common mechanism • Apoptosis – programmed cell death; characterized by a predefined sequence of events resulting in cell separation in apoptotic bodies-Cell shrinks, chromatin condenses, cell breaks into fragments, no inflammation. • Bystander (abscopal) effect – cells directly affected by radiation release cytotoxic molecules inducing death in neighbouring cells
  • 11. • Additional mechanisms under investigation: – 1. Autophagic: cell degradation of unnecessary or dysfunctional cellular components through lysosomes 2. Necrotic: cell swells, leakage of membrane, inflammation 3. Entosis: cell death by invasion
  • 12. Assays for dose-response relationships • Clonogenic end points • Depend directly on reproductive integrity of individual cells (cell survival) • Cell regrowth in situ and by transplantation into another site • Functional end points • Reflect the minimum number of functional cells remaining in a tissue or organ • Dose-response can be inferred from multi-fraction experiments • More pertinent to radiation therapy
  • 13. Early and late responding tissues • Observation: cells of different tissues demonstrate different response rates to the same radiation dose • Rapidly dividing self-renewing tissues respond early to the effects of radiation; examples: skin, intestinal epithelium, bone-marrow • Late-responding tissues: spinal cord, lung, kidney • Early or late radiation response reflects different cell turnover rates
  • 16. Skin colonies • Central area is given a test dose and monitored for cell re- growth • Image showing nodule of mouse skin regrowing from single survival cell in treated area
  • 17. • There are practical limits to the range of doses • Determine D0 =1.35 Gy from the single dose curve • Dq =3.4 Gy from the curve separation • Values for D0 and Dq are similar to those obtained in vitro
  • 18. Crypt cells of the mouse jejunum • Intestinal epithelium is a classic example of a self renewing system • Crypt cells divide rapidly and replenish cells on the top of villi • Mice are given total body irradiation and are sacrificed after 3.5 days • Radiation effect is assessed based on the number of regenerating crypts per circumference of the sectioned jejunum
  • 19. • A: Section of mouse jejunum taken 3.5 days after a total body dose in excess of 10 Gy. Note the shortened villi and the regenerating crypts. • B: Regenerating crypts shown at a higher magnification.
  • 20. -Survival curves for crypt cells in the mouse jejunum exposed to single or multiple doses of gamma-rays (1–20 fractions). The score of radiation damage is the number of surviving cells per circumference (i.e., the number of regenerating crypts per circumference of the sectioned jejunum). This quantity is plotted on a logarithmic scale against radiation dose on a linear scale -The D0 for the single-dose survival curve is about 1.3 Gy. -The shoulder of the survival curve is very large. The separation between the single-dose survival and two- dose survival curves indicates that the Dq is 4 to 4.5 Gy.
  • 21. Testes Stem Cells A: Histology of normal testis. B: Histology of testis 35 days after a dose of 9 Gy of gamma-radiation. Some tubules are completely devoid of spermatogenic epithelium and some are not.
  • 22. Single- and split- dose survival curves for spermatogenic stem cells of the mouse testis. The D0 is about 1.68 Gy. The Dq, assessed from the horizontal separation of the single- and split-dose curves, is about 2.7 Gy.
  • 23. Kidney tubules • Late responding tissue • One kidney per mouse is irradiated and examined 60 weeks later • Rate of response as time required for depletion of the epithelium after a single dose of 14Gy: – 3 days in jejunum – 12 to 24 days in the skin – 30 days in the seminiferous tubules of the testes – 300 days in the kidney tubules
  • 24. A. Normal ,proximal tubules in contact with the capsule B: Sixty weeks after irradiation with 13 Gy. Note normal proximal tubules and glomeruli amid ghosts of de-epithelialized tubules
  • 25. The time required for depletion of the epithelium after a single dose of 14 Gy is about • 3 days in the jejunum • 12 to 24 days in the skin • 30 days in the seminiferous tubules of the testes • 300 days in the kidney tubules.
  • 26. Clonogenic End Points: Donor Recipient Approach • Systems in which cell survival is assessed by transplantation into another site:  Bone-marrow stem cells Thyroid Mammary gland cells
  • 27. Cells Transplanted to Another Site Bone Marrow Stem Cells From the donor mouse, a cell suspension is made of nucleated isologous bone marrow. A known number of cells are injected into recipient mice previously irradiated with a 9- Gy total body dose. The spleen is removed from each recipient mouse 9 or 10 days later, and the number of nodules are counted.
  • 28. • About 104 cells must be injected into a recipient animal to produce one spleen colony because most of the cells in the nucleated isologous bone marrow are fully differentiated cells and would never be capable of forming a colony.
  • 29. Mammary and Thyroid Cells • To generate a survival curve for mammary or thyroid gland cells in the rat, cells may be irradiated in vivo before the gland is removed from donor animals and treated with enzymes to obtain a monodispersed cell suspension. Known numbers of cells are injected into the inguinal or interscapular white fat pads of recipient animals. • Under appropriate host conditions and grafted cell numbers, the injection of mammary cells gives rise to mammary structures that are morphologically and functionally normal. One such mammary structure may develop from a single cell. By 3.5 weeks after the injection of mammary cells, positive growth is indicated by alveolar units.
  • 30. Clonogenic Assays: Summary • Radiosensitivity of a cell line is determined by the curve shoulder (Dq parameter) • Significant variability observed
  • 32. Dose-response Curves For Functional End Points • Can be obtained on pig and rodent skin by assessing skin reaction • For mouse lung system based on breathing rate, assess early and late response • Spinal cords of rats by observing myelopathy after local irradiation complex system – various syndromes are similar to those described in humans
  • 33. Skin
  • 34. Lung • Early response (i.e., Pneumonitis) by 16-36 weeks, • Late response (i.e., Fibrosis) by 52 weeks
  • 35. Spinal Cord System • Assess late damage caused by local irradiation of the spinal cords of rats • First symptoms develop after 4 to 12 months • Delayed injuries peak at 1 to 2 years post-irradiation • The regimen of dose delivery has a strong effect on the resultant effect such as the extend of necrosis, loss of functionality, etc. • Obtain the information on the tolerance to radiation
  • 36. • Dose-response relationship is steep • Fractionation demonstrates dramatic sparing • Latency decreases with increase in dose • The region of cord irradiated
  • 37. • The total volume of irradiated tissue has to have an effect on the resultant injury • Functional subunits (FSUs) in a spinal cord are arranged in linear fashion therefore above a certain length of ~1cm the dependence is very weak
  • 38. INFERRING THE RATIO α/𝜷 FROM MULTIFRACTION EXPERIMENTS IN NONCLONOGENIC SYSTEMS • The dose–response relationship is represented adequately by the LQ formulation: •S= e -αD-𝜷D2 • in which S is the fraction of cells surviving a dose, D, and α and 𝜷 are constants. • Each dose in a fractionated regimen produces the same biologic effect. • Full repair of sublethal damage takes place between dose fractions, but no cell proliferation occurs.
  • 39. SUMMARY • The relationship between dose and incidence is sigmoid for both tumor control and normal tissue damage. • The ratio of tumor response to normal tis- sue damage is called the therapeutic ratio or therapeutic index. • The therapeutic index can be manipulated by dose fractionation or by the use of drugs that preferentially increase tumor response. • After irradiation, most cells die a mitotic death; that is, they die in attempting the next or a later mitosis. In some tissues, cells die by apoptosis, which is a programmed cell death. • Systems involving clonogenic end points (i.e., cell survival) for cells of normal tissues include some in which cells regrow in situ and some in which cells are transplanted to another site.
  • 40. • In situ regrowth techniques include skin colonies, crypts in the jejunum, testes stem cells, and kidney tubules. Single dose experiments can yield the slope (D0) of the dose- response curve over a range of high doses. Multifraction experiments allow the whole dose-response curve to be reconstructed. • Systems in which cell survival is assessed by transplantation into another site include bone marrow stem cells, thyroid cells, and mammary cells. • Dose–response curves for mammary and thyroid cells can be obtained by transplanting them into fat pads of recipient animals. • The radiosensitivity of cells from normal tissues varies widely. The width of the shoulder of the curve is the principal variable. Jejunal crypt cells have a very large shoulder; bone marrow stem cells have little, if any, shoulder. Most other cell types studied in clonogenic assays fall in between.
  • 41. Dose–response curves for functional end points, distinct from cell survival, can be obtained as follows: 1. Pig skin and rodent skin—by measuring skin reactions. 2. Early and late response of the lung—by measuring breathing rate. 3. Spinal cord—by observing myelopathy a. Paralysis develops after a latency of months to years. b. Early lesions are limited to white matter; late delayed injury may have a vascular basis. c. Spinal cord damage is very sensitive to fractionation—α/𝜷 of about 1.5 Gy. d. Sublethal damage repair probably has “fast” and “slow” components. e. If multiple fractions per day are used, the interfraction interval should be at least 6 to 8 hours. f. Functional subunits are arranged serially like links in a chain. g. For short lengths of cord, tolerance dose varies markedly with cord length irradiated.
  • 42. • The shape of the dose–response relationship for functional end points, obtained from multi-fraction experiments, is more pertinent to radiotherapy than clonogenic assays. • The ratio α/𝜷 (the dose at which the linear and quadratic components of radiation damage are equal) may be inferred from multifraction experiments in systems scoring non-clonogenic end points.